You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Kwality Pharmaceuticals Ltd"

Kwality Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended September 2021

  • 14/10/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Board Meeting Intimation for For Considering Unaudited Financial Results For The Half Year Ended On

  • 12/10/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Shareholder Meeting / Postal Ballot-Outcome of AGM

  • 01/10/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Closure of Trading Window

  • 30/09/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Notice Of 38TH AGM To Be Held On Thursday 30Th September 2021

  • 06/09/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Intimation Of Annual General Meeting And Book Closure

  • 06/09/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of Board Meeting Held On September 06 2021

  • 06/09/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 28/08/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended June 2021

  • 16/07/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 16/07/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Audited Standalone And Consolidated Financial Results For The Half Year & Year Ended 31St March 2021

  • 30/06/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Standalone And Consolidated Financial Results For The Half Year & Year Ended 31St March 2021

  • 30/06/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 26/06/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Board Meeting Intimation for CONSIDERING THE STANDALONE & CONSOLIDATED AUDITED FINANCIAL RESULTS FOR

  • 22/06/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund R

  • 27/04/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Shareholding for the Period Ended March 31 2021

  • 21/04/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulat

  • 17/04/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2021

  • 16/04/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Closure of Trading Window

  • 01/04/2021
  • |
  • bse

Kwality Pharmaceuticals Ltd Appointment Of Internal Auditor

  • 01/04/2021
  • |
  • bse
.